U.S. Healthcare Services Stock News

ExlService Holdings (EXLS) has come back into focus after recent trading saw the stock close at US$28.16, drawing attention to how its current valuation lines up with its financial profile and market performance. See our latest analysis for ExlService Holdings. Recent trading has been choppy for ExlService Holdings, with the share price falling 1.85% over the last day but rising 3.15% over the past week. The year to date share price return is down 31.67%, and the 1 year total shareholder...

Prudential Financial (PRU) is in the spotlight after reporting stronger than expected first quarter earnings, with firmer investment income, solid annuity and retirement demand, and management underscoring ongoing business transformation and retirement focused product expansion. See our latest analysis for Prudential Financial. The stronger first quarter update has arrived alongside a clear pick up in momentum, with Prudential Financial’s 30 day share price return of 11.27% and 90 day share...

In early July 2026, NRSInsights reported that IDT’s June 2026 same-store sales rose 3.4% year over year, while units sold fell 1.5% compared to a year earlier. The combination of higher same-store sales but fewer units sold suggests consumers may be purchasing fewer items at higher prices or shifting toward higher-value products, reshaping how IDT’s retail data is interpreted. We’ll now examine how June’s 3.4% same-store sales growth, alongside softer unit volumes, feeds into IDT’s existing...

Corcept Therapeutics has delivered very strong long term share price gains over the past five years, yet its latest valuation checks lean more cautious, leaving investors weighing a powerful performance track record against a weak overall value score. Corcept Therapeutics is up about 346.1% over five years, which puts the recent share price in the context of a very strong run already behind it. Progress with cortisol modulating drugs, including Lifyorli and the resubmitted relacorilant...

Geopolitics just moved back to the front of the market’s attention, with U.S. strikes on Iran, drone and missile attacks across the Gulf, and oil prices reacting sharply. When tensions spill into shipping lanes and supply chains, some stocks can gain new contracts or attention, while others face higher risks and costs. This article looks at how that mix of risk and opportunity connects to the latest Defense and Aerospace Stocks screener and highlights 3 stocks that appear positively exposed...

Arrowhead Pharmaceuticals (ARWR) has drawn investor attention after recent share price moves, with the stock up about 4.1% over the past day but down roughly 8.3% over the past month. See our latest analysis for Arrowhead Pharmaceuticals. The recent 1 day share price return of 4.1% comes after a softer 30 day share price return of 8.3% and a 9.6% share price return year to date. The 1 year total shareholder return of very large magnitude suggests Arrowhead Pharmaceuticals has already...

Danaher recently benefited from optimism around its July 21 Q2 2026 earnings release, with analysts expecting modest revenue and earnings growth supported by strength in bioprocessing and filtration, plus contributions from acquisitions like Masimo and Leica Biosystems’ agreement to acquire StatLab Medical Products. Investors are increasingly focused on how these diagnostics-expanding deals and bioprocessing momentum might offset ongoing cost pressures, high debt levels, and softness in...

Truist Financial (TFC) is back in focus after reporting second quarter 2026 earnings that topped expectations, outlining higher net income, a refocused lending mix, and continued share buybacks. See our latest analysis for Truist Financial. The share price of Truist Financial has climbed over recent months, with a 30 day share price return of 8.99% and a 1 year total shareholder return of 24.02%. This suggests recent earnings, lending shifts and buybacks are being viewed as supportive. The 3...

Bitdeer Technologies Group has broken ground on a new 187,000-square-foot advanced electronics manufacturing facility in Sparks, Nevada, marking a US$36 million move into domestic production of its SEALMINER computing hardware and creating 70 local jobs. This facility, set to augment Bitdeer’s existing U.S. data centers and innovation hub, signals a deeper commitment to U.S.-based, vertically integrated computing hardware manufacturing within Nevada’s growing tech ecosystem. Next, we’ll...

Abbott Laboratories (ABT) just posted Q2 2026 revenue of about US$12.6b with basic EPS of US$0.53, alongside trailing twelve month revenue of roughly US$46.6b and EPS of US$3.11. Over recent quarters the company has seen revenue move from about US$11.1b in Q2 2025 to US$12.6b in Q2 2026, while quarterly EPS shifted from US$1.02 to US$0.53. This sets up a results season where investors are likely to focus closely on how margins are holding up in the current mix of growth drivers. See our full...

AI trading signals put Kirby in focus Fresh AI generated trading signals around Kirby (KEX) have pushed the stock into the spotlight, with the models flagging neutral near and mid term readings, as well as a long term strong positive bias. The same signals highlight a mid channel oscillation pattern and outline a short setup with defined downside potential and limited indicated risk, along with suggested institutional style long, breakout, and hedging approaches. See our latest analysis for...

Palantir Technologies (PLTR) is back in focus after a series of AI focused partnerships and government wins, including new work with the U.S. Small Business Administration and enterprise clients across insurance and cloud infrastructure. See our latest analysis for Palantir Technologies. Despite the stream of new AI partnerships and government work, Palantir Technologies’ share price has been under pressure, with the stock down 21.14% on a year to date share price return and the 1 year total...

Tesla stock is back in focus after a strong multi year run, yet the latest valuation checks suggest the shares are pricing in a lot of good news rather than offering clear value. Over the last 5 years, Tesla has returned about 77.6%, which puts current buyers in a very different position to investors who entered much earlier. Expectations around areas like robotaxis, Optimus and energy storage can support a rich valuation. At the same time, regulatory scrutiny on autonomy and rising...

Matador Resources (MTDR) has drawn fresh investor attention after recent trading, with the stock last closing at $53.80. The move comes alongside mixed short term returns and a longer record of positive performance over multiple years. See our latest analysis for Matador Resources. Recent trading puts Matador Resources on a firmer footing, with a 7 day share price return of 4.79% and a 30 day share price return of 6.75%. However, the 90 day share price return declined 3.24%. Over the longer...

Dynex Capital has delivered a 60.9% return over the past three years, yet the stock still screens as undervalued on earnings multiples while scoring weakly on broader valuation checks. This leaves investors weighing how much of that performance is already reflected in the current US$13.33 share price. Over the past three years, Dynex Capital has returned 60.9%, which puts recent short-term moves into context as part of a longer period of shareholder gains. For a mortgage REIT like Dynex...

In the past week, Wells Fargo & Company reported stronger-than-expected second-quarter 2026 results, with net income of US$6,407 million and continued stock buybacks alongside a planned dividend increase, while also issuing several new senior unsecured fixed-income notes across maturities from 2030 to 2046. The bank coupled these financial updates with ongoing technology investments, including the rollout of its AI Teammate tool for wealth advisors, signaling an emphasis on digital...

Palo Alto Networks stock has delivered a very large 5 year return, yet the latest valuation work suggests investors are now paying a premium, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to the shares screening as overvalued. Palo Alto Networks has returned about 4.4x over 5 years, which puts extra focus on whether the current price already embeds optimistic expectations. Strong interest in AI powered cybersecurity and recent sector wide...

Bank of America stock has climbed strongly in recent years, yet current valuation checks suggest the market price may still sit below what its intrinsic value estimate and earnings multiples imply. Over the past 3 years, Bank of America has returned 106.5%, which puts extra focus on whether the current price still leaves room for further value to be realised. Recent enthusiasm around Bank of America's trading, investment banking, and AI related financing activity can support expectations for...

With the Federal Reserve striking a tougher tone on inflation and markets bracing for the possibility of higher for longer interest rates, large cap value stocks are back in focus for investors looking for potentially steadier ground. The Large-Cap Value Stocks screener picks out bigger companies that combine relatively low valuations, solid balance sheets, and moderate risk. In a setting where inflation sits at 3.5% and the prospect of further rate hikes depends on each new data release,...

MSCI (MSCI) has drawn fresh investor attention after analysts highlighted anticipated year over year increases in earnings per share and revenue, along with an expanded partnership with UBS focused on improving transparency in private markets data. See our latest analysis for MSCI. MSCI's recent UBS partnership and private markets initiatives come after a steady run in the stock, with a 90 day share price return of 10.57% and a 1 year total shareholder return of 10.30%, suggesting momentum...

Oscar Health (OSCR) is back in focus after recent analyst reports cited substantial upward revisions in earnings estimates and a top Zacks Rank #1 rating, prompting fresh attention from both value and momentum investors. See our latest analysis for Oscar Health. The recent attention on Oscar Health has come alongside a sharp swing in momentum, with a 1-day share price return of 0.83% and a 7-day share price return down 4.72%, set against a 90-day share price return of 84.29% and a 1-year...

EchoStar CEO Hamid Akhavan has resigned, with leadership duties moving to Charles W. Ergen and Thomas A. Cullen. The change comes alongside a shift in EchoStar's strategic direction affecting how key business units are run. Investors are assessing what the new leadership structure could mean for culture, execution, and the company’s future focus. EchoStar, traded as NasdaqGS:ECHO, is entering a transition period at a time when its share price sits at $92.0. The stock is down 4.2% over the...

Intuitive Surgical (ISRG) has released its Q2 2026 numbers, with revenue of US$2.9 billion and basic EPS of US$2.31, set against trailing 12 month revenue of US$11.0 billion and EPS of US$8.84. Over recent quarters, the company has seen revenue move from US$2.44 billion in Q2 2025 to US$2.89 billion in Q2 2026, while quarterly EPS shifted from US$1.84 to US$2.31, with trailing earnings up 20.4% over the past year and 16.7% per year over the past five years. With a net profit margin of 28.4%...

Lennox International has recently drawn investor attention as its digital platforms, AI-based pricing tools, and proprietary data analytics begin to meaningfully influence its operations and revenue mix. This focus on technology is strengthening the company’s pricing power and recurring revenue streams, which may be reshaping how investors view its longer-term earnings potential. We’ll now examine how Lennox’s push into AI-driven pricing and analytics may influence its existing investment...